Skip to content

Public FDA record

Z-1676-2015: D2-40 (Lymphatic Marker); For In Vitro Diagnostic; Catalog number: PM266AA Product Usage: In Vitro Diagn

Recall record Z-1676-2015 for Biocare Medical, LLC. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1676-2015
Company in FDA record
Biocare Medical, LLC
FDA classification date
May 26, 2015
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class III

Reason stated in the source

Firm discovered that incorrect Instructions for Use were shipped with one lot of D2-40.

Source facts

Action
Biocare Medical sent a Medical Device Notification letter dated May 6, 2015 to their customers. The letter identified the affected product, problem and actions to be taken. Customers were instructed to complete all actions listed on the enclosed Return Response Form.
Initiated
2015-05-06
Root cause
Labeling mix-ups
Terminated
2015-06-04
Distribution
Worldwide Distribution - US Nationwide in the states of: MI, SC, NC, AZ, CA, MO, WI and Hungary, Spain and Austria.
Recall number
Z-1676-2015
Recall status
Terminated
CDRH record ID
136887
FDA classified
2015-05-26
Recall event number
71229

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗